Search our
Current Studies
A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes (SUSTAIN FORTE)
Location(s): Jacksonville- LaVilla (Downtown)
Condition: Diabetes
A Phase II Randomized, Double Blind, Placebo-controlled, Parallel Group, Multicentre Study to Evaluate the Safety and Efficacy of Repeated Oral Doses of Blautix in Adult Subjects With Irritable Bowel Syndrome (IBS) Subtypes IBS-C and IBS-D
Location(s):
Condition:
The study will explore the effects of three different InterStim amplitude settings on overactive bladder symptoms (OAB).
Location(s): Jacksonville (Headquarters)
Condition: Urology
A Randomized, Phase 3, Open-Label Trial Comparing the Effect of Tirzepatide Versus Titrated Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes
Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown), Macon
Condition: Diabetes
A Double-blind Randomized Placebo-controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Atherosclerotic Cardiovascular Disease
Location(s): St. Augustine
Condition: Cholesterol, Heart Disease
A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes (FOCUS)
Location(s): Jacksonville (Headquarters)
Condition: Diabetes
A Multicentre International Randomized Parallel Group Double-blind Placebo-controlled Clinical Trial of EMPAgliflozin Once Daily to Assess Cardio-renal Outcomes in Patients With Chronic KIDNEY Disease
Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown)
Condition: Kidney Disease
A Phase III Randomised, Double-blind Trial to Evaluate Efficacy and Safety of Once Daily Empagliflozin 10 mg Compared to Placebo, in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF)
Location(s): Jacksonville (Headquarters)
Condition: Heart Failure
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk (SCORED)
Location(s): Jacksonville (Headquarters)
Condition: Diabetes, Heart Disease, Kidney Disease
The purpose of the study is to collect data about how well U-100 Regular Human Insulin can be used in the V-Go Insulin Delivery Device compared to U-100 Rapid Acting Insulin in the V-Go Insulin Delivery Device. The data collected will be used to see how much subjects’ blood sugar levels change over time after they switch from using U-100 Rapid Acting Insulin to U-100 Regular Human Insulin within their V-Go Insulin Delivery Device.
Location(s): Jacksonville- LaVilla (Downtown), Macon
Condition: Diabetes
A multicenter, randomized, open-label, active-controlled Phase 3 study for the maintenance treatment of anemia in subjects with NDD-CKD
Location(s): Jacksonville- LaVilla (Downtown)
Condition: Diabetes, Kidney Disease
A multicenter, randomized, open-label, active-controlled Phase 3 study for the correction of anemia and maintenance of hemoglobin (Hb) in subjects with NDD-CKD
Location(s): Jacksonville- LaVilla (Downtown)
Condition: Diabetes, Kidney Disease
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Location(s): Jacksonville (Headquarters)
Condition: Heart Disease, Heart Failure